GWM
ELOX

Geneos Wealth Management’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Geneos Wealth Management’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2
Closed -$1K – 2509
2018
Q3 		$1K Hold
2
– – ﹤0.01% 2393
2018
Q2 		$1K Buy
+2
New +$1.3K ﹤0.01% 2240

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
NEPWA
New England Private Wealth Advisors Wellesley, Massachusetts $866M AUM 15.25% 1-Year Est. Return

Geneos Wealth Management's ELOX Position: Q4 2018 in Review

Geneos Wealth Management sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2018, closing a stake of 2 shares — an estimated $1K sold.

Geneos Wealth Management first reported a position in ELOX in Q2 2018 and held it in 2 quarters. The position peaked at $1K in Q3 2018. 38 funds tracked by Wall St. Rank hold ELOX as of Q4 2018.

  • Geneos Wealth Management reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Geneos Wealth Management sold 2 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2018, an estimated $1K.
  • Geneos Wealth Management first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
  • Geneos Wealth Management's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $1K in Q3 2018.
  • 38 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2018.

Based on Geneos Wealth Management's 13F filing for Q4 2018, filed 7 Sep 2021.